Oral adverse drug reactions in various medications
Authors:
Ludmila Kameníková; Hassan Farghali
Published in the journal:
Čes. slov. Farm., 2016; 65, 64-69
Category:
Review Articles
Summary
The goal of the article is to emphasize the fact that adverse drug effects which are manifested in the oral cavity are exhibited in two ways. This may occur either after a direct application of the preparation used in dental practice, or due to the application of the drug for nondental purpose. That is why the adverse effects of medicines prescribed by various clinical specialists should be considered by stomatologists in their own clinical practice. Examples are reported of some serious drug adverse effects manifested on the oral mucous membrane and gum. Attention is paid to the classes which reveal adverse reactions after applications as local anaesthetics, corticosteroids and others.
Key words:
oral adverse drug reactions • local anaesthetics • corticosteroids
Zdroje
1.Institute of Medicíne, National Academy Press, 2000 – Lazaroni J. Adverse reactions of drugs JAMA 1998; 279/15, 1200–1206.
2. Houba R., Zemen J., Bartáková V. Rukověť zubního lékaře – pacient se zdravotním rizikem. 1. vydání. Praha: Vydala stomatologická komora (Malá edice) ve spolupráci s Havlíček Brain Team 2012; 198–220.
3. Ščigel V. Repetitorium klinické farmakologie pro praxi zubního lékaře (doplněné a rozšířené vydání). 2. vydání. Praha: Vydala stomatologická komora (Malá edice) ve spolupráci s Havlíček Brain Team 2010.
4. Becker D. E. Adverse drug reactions in dental practice. Anesth. Prog. 2014; 61, 26–34.
5. Becker D. E. Drug allergies and implications for dental practice. Anesth. Prog. 2013; 60, 188–197.
6. Sambrook P. J, Goss A. N. Severe adverse reactions to dental local anesthetics: prolonged mandibula and lingual nerve anaesthesia. Austr. Dent. J. 2011; 56, 154–159.
7. Sambrook P. J, Smith W., Elijah J., Goss A. N. Severe adverse reactions to dental local anaesthetics: systemic reactions. Austr. Dent. J. 2011; 56. 148–153.
8. Sumer M., Misir F., Celebi N., Mumlali M. A. Comparison of injection with articaine with adrenaline, prilocaine with phenylpressin and lidocaine with adrenaline. Med. Oral Pathol. Oral Cir. Bucal 2008; 13, E427–430.
9. Oral and Dental Expert Group. Therapeutic Guidelines: Oral and Dental. Version I. Melbourne: Therapeutics Guidelines Limited 2007.
10. Becker D. E., Reed K. I. Local anesthetics: review of pharmacological considerations. Anesth. Prog. 2012; 59, 90–102.
11. Garisto G. A., Gaffen A. S., Lawrence H. P., Tenenbaum H. C., Haas D. A. Occurence of paresthesia after dental local anesthetic administration in the United States. J. Am. Dent. Assoc. 2010; 141, 836–844.
12. Hillerup S., Jensen R. H., Ersboll B. K. Trigeminal nerve injury associated with injection of local anesthetics: needle lesion or neurotoxicity? J. Am. Dent. Assoc. 2011; 142, 531–539.
13. Carbone M., Goss E., Carrozzo M., Castellano S., Conrotto D., Broccoletti R. Systemic and topícal corticosteroid treatment of oral lichen planus: a comparative study with long-term follow up. J. Oral Pathol. Med. 2003; 32, 323–329.
14. Decani S., Federighi V., Baruzzi E., Sardella A., Lodi G. Iatrogenic Cushing’s syndrome and topical steroid therapy: case series and review of the literature. J. Dermatos. Treatment 2014; 25, 495–500.
15. Carbone M., Arduino P. G., Carrozzo M., Calazzo G., Broccoletti R., Conrotto D. Topícal clobetasol in the treatment of atrophic-erossive oral lichen planus: a randomized controlled trial to compare two preparations with different concentrations. J. Oral Pathol. Med. 2009; 38, 227–233.
16. González-Moles M. A. The use of topícal corticoids in oral patology. Med. Oral Patol. Oral Cir. Bucal 2010; 15, e827–831.
17. Al Johani K. A., Hegarty A. M., Porter S. R., Fedele S. Calcineurin inhibitors in oral medicíne. J. Am. Acad. Dermatos. 2009; 61, 829–840.
18. Jewell C. M., Cidlowski J. A. Molecular evidence for a link between the N363S glucocorticoid receptor polymorphism and altered gene expression. J. Clin. Endocrinol. Metab. 2007; 92, 3268–3277.
19. Huizenga N. A., Koper J. W., De Lange P. A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J. Endocrinol. Metab. 1998; 83, 144–151.
20. Delaney J. A., Opatrny L., Brophy J. M., Suissa S. Drug-drug Interactions between antithrombotic medications and the risk of gastrointestinal bleeding. CMAJ 2007; 177, 347–351.
21. Becker D. E. Basic and clinical pharmacology of autonomic drugs. Anesth. Prog. 2012; 59, 159–168.
22. Abramowicz M. Acetaminophen safety-deja vu. Med. Lett. Drugs Ther. 2009; 51, 53.
23. Grosser T., Smyth E., Fitzgerald G. A. Anti-inflammatory, antipyretik, and analgesic agents: pharmacotherapy of gout. In: Brunton L. L., Chabnes B. A., Knollmann B. C. (eds.). Goodman and Gilman’s the Pharmacological Basis of Therapeutics. 12th ed. New York, NY: McGraw-Hill Companies Inc. 2011.
24. Ščigel V. Repetitorium klinické farmakologie pro praxi zubního lékaře (doplněné a rozšířené vydání). 2. vydání. Praha: Vydala stomatologická komora (Malá edice) ve spolupráci s Havlíček Brain Team 2010, 163.
25. Lodi G., Tarozzi M., Sardella A., Demarosi F., Canegallo L., Di Benedetto D. Miconazole as adjuvant therapy for oral lichen planus: a double-blind randomized controlled trial. Br. J. Dermatos. 2007; 156, 1336–1341.
26. Brasileiro C. B., Abreu M. H., Mesquita R. A. Critical review of topícal management of oral hairy leukoplakia. World J. Clin. Cases 2014; 16, 253–256.
Štítky
Pharmacy Clinical pharmacologyČlánok vyšiel v časopise
Czech and Slovak Pharmacy
2016 Číslo 2
Najčítanejšie v tomto čísle
- Oral adverse drug reactions in various medications
- Potential immunomodulatory and antiinflammatory mechanisms of probiotics
- The evaluation of the prevalence of constipation at the Centre of clinical gerontology
- Phenolic compounds of the genus Iris plants (Iridaceae)